Notice Pursuant to the National Cooperative Research and Production Act of 1993-Open Source Imaging Consortium, Inc., 76107 [2020-26188]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices
2021. In addition, any person who has
not entered an appearance as a party to
the investigations may submit a written
statement of information pertinent to
the subject of the investigations,
including statements of support or
opposition to the petition, on or before
March 25, 2021. On April 14, 2021, the
Commission will make available to
parties all information on which they
have not had an opportunity to
comment. Parties may submit final
comments on this information on or
before April 16, 2021, but such final
comments must not contain new factual
information and must otherwise comply
with § 207.30 of the Commission’s rules.
All written submissions must conform
with the provisions of § 201.8 of the
Commission’s rules; any submissions
that contain BPI must also conform with
the requirements of §§ 201.6, 207.3, and
207.7 of the Commission’s rules. The
Commission’s Handbook on Filing
Procedures, available on the
Commission’s website at https://
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf, elaborates
upon the Commission’s procedures with
respect to filings.
Additional written submissions to the
Commission, including requests
pursuant to § 201.12 of the
Commission’s rules, shall not be
accepted unless good cause is shown for
accepting such submissions, or unless
the submission is pursuant to a specific
request by a Commissioner or
Commission staff.
In accordance with §§ 201.16(c) and
207.3 of the Commission’s rules, each
document filed by a party to the
investigations must be served on all
other parties to the investigations (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
Authority: These investigations are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to § 207.21 of the Commission’s
rules.
By order of the Commission.
Issued: November 20, 2020.
Lisa Barton,
Secretary to the Commission.
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Antitrust Division
Drug Enforcement Administration
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Open Source Imaging
Consortium, Inc.
Notice is hereby given that, on
November 13, 2020, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), Open
Source Imaging Consortium, Inc.
(‘‘Open Source Imaging Consortium’’)
has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Vida Diagnostics, Inc.,
Coralville, IA; and University of Genoa,
Genoa, ITALY, have been added as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Open Source
Imaging Consortium intends to file
additional written notifications
disclosing all changes in membership.
On March 20, 2019, Open Source
Imaging Consortium filed its original
notification pursuant to Section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on April 12, 2019 (84 FR 14973).
The last notification was filed with
the Department on August 19, 2020. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on August 28, 2020 (85 FR 53402).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2020–26188 Filed 11–25–20; 8:45 am]
BILLING CODE P
[FR Doc. 2020–26164 Filed 11–25–20; 8:45 am]
BILLING CODE 7020–02–P
jbell on DSKJLSW7X2PROD with NOTICES
76107
[Docket No. DEA–744]
Importer of Controlled Substances
Application: Meridian Medical
Technologies
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Meridian Medical
Technologies has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 28, 2020. Such
persons may also file a written request
for a hearing on the application on or
before December 28, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on November 3, 2020,
Meridian Medical Technologies, 2555
Hermelin Drive, Saint Louis, Missouri
63144, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Schedule
Morphine ..................................................................................................................................................................
9300
II
The company manufactures a product
containing morphine in the United
VerDate Sep<11>2014
19:29 Nov 25, 2020
Jkt 253001
States. The company exports this
product to customers around the world.
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
The company has been asked to ensure
that its product, which is sold to
E:\FR\FM\27NON1.SGM
27NON1
]]>Agencies
[Federal Register Volume 85, Number 229 (Friday, November 27, 2020)]
[Notices]
[Page 76107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26188]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Open Source Imaging Consortium, Inc.
Notice is hereby given that, on November 13, 2020, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Open Source Imaging
Consortium, Inc. (``Open Source Imaging Consortium'') has filed written
notifications simultaneously with the Attorney General and the Federal
Trade Commission disclosing changes in its membership. The
notifications were filed for the purpose of extending the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances. Specifically, Vida Diagnostics,
Inc., Coralville, IA; and University of Genoa, Genoa, ITALY, have been
added as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and Open Source Imaging Consortium
intends to file additional written notifications disclosing all changes
in membership.
On March 20, 2019, Open Source Imaging Consortium filed its
original notification pursuant to Section 6(a) of the Act. The
Department of Justice published a notice in the Federal Register
pursuant to Section 6(b) of the Act on April 12, 2019 (84 FR 14973).
The last notification was filed with the Department on August 19,
2020. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on August 28, 2020 (85 FR 53402).
Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2020-26188 Filed 11-25-20; 8:45 am]
BILLING CODE P
